Current Fellows' Research & Clinical Interests

(Preceptor and Preceptor’s Department or Division)

  • Oyebimpe Adesina, MD (Jason Gotlib, Stan Schrier, Hematology)
    Long term sequelae of Sickle Cell disorder and mitigating factors in affected adults
  • Alexey Aleshin, MD, MBA
    Clinical fellow with July 2015 start; will begin research in January 2017
  • Jennifer Caswell-Jin, MD (Christina Curtis, Oncology and Genetics; Allison Kurian, Oncology and Health Research & Policy)
    Genomics of breast tumor response to treatment
  • Mark P. Chao, MD, PhD (Irving Weissman, Pathology; Ravi Majeti, Hematology)
    Modeling hematologic malignancies through induced pluripotent stem cells
  • Viola Chen, MD (Alice Fan, Oncology; Shan Wang, Electrical Engineering)
    Using nanotechnology to profile renal cell carcinoma circulating tumor cells and host immune response to predict response to targeted therapy
  • Jody Chuang, MD, PhD (Joel Neal, Heather Wakelee, Oncology)
    Clinical trials and other studies in thoracic oncology
  • Brian Dietrich, MD
    Clinical fellow with July 2015 start; will begin research in January 2017
  • Matthew Frank, MD, PhD (Ronald Levy, Oncology)
    Novel treatment strategies in lymphoma
  • Joshua Gruber, MD, PhD (James Ford, Oncology and Michael Snyder, Genetics)
    Measuring somatic mutation rate in patients at high risk for malignancy
  • Robert W. Hsieh, MD, PhD (Michael Clarke, Oncology)
    RNAi screening in primary human breast cancer cells to identify regulators of oncogenic growth
  • David Iberri, MD
    Clinical fellow; Hematology Clinic and Med 9
  • Tyler P. Johnson, MD, PhD
    Clinical fellow
  • Adel Kardosh, MD, PhD (Ronald Levy, George Fisher, Oncology)
    Cancer immunology in solid malignancies
  • Gregory Kaufman, MD
    Clinical fellow with July 2015 start; will begin research in January 2017
  • David Matthew Kurtz, MD (Ash Alizadeh, Oncology; Sanjiv Gambhir, Radiology)
    ARTS (Advanced Residency Training Program) Bioengineering PhD Program - Monitoring therapeutic responses in lymphoma
  • Ryan Lynch, MD (Ranjana Advani, Oncology)
    Lymphoma: outcomes research, clinical trials
  • Michael Mancuso, MD, PhD
    Clinical fellow with July 2015 start; will begin research in January 2017
  • Wendy Pang, MD, PhD (Irving Weissman, Pathology & Stem Cell Biology; Judith Shizuru, BMT)
    Targeting blood-forming stem cells in myelodysplastic syndrome
  • Ameen A. Salahudeen, MD, PhD (Calvin Kuo, Hematology)
    Modeling aerodigestive malignancies through primary organoid culture
  • Sumit  A. Shah, MD, MPH (Sandy Srinivas, Oncology)
    Evaluation of novel healthcare delivery systems to improve access to care in resource poor areas
  • Tanaya Shree, MD, PhD
    Clinical fellow; will begin research in March 2016
  • Brian Sworder, MD, PhD
    Clinical fellow with July 2015 start; will begin research in January 2017
  • Tian Yi Zhang, MD, PhD (Ravi Majeti, Hematology)
    Deciphering the cause of cytopenias in AML
  • Jeffrey Zweig, MD
    Clinical fellow with July 2015 start; will begin research in January 2017

Instructors' Research & Clinical Interests

  • Anosheh Afghahi, MD (Melinda Telli, Oncology)
    DNA repair targeted strategies in triple-negative and hereditary breast cancer
  • Michael Khodadoust, MD, PhD (Ronald Levy, Ash Alizadeh, Oncology)
    Anti-tumor immune responses in lymphoma
  • Manali Patel, MD (Oncology)
    GI Oncology research
  • Yu Wong, MD, PhD (Mark Davis, Microbiology and Immunology)
    Design of novel approach to measure T cell repertoire. Translational research in breast cancer